Michael Arenberg - 23 Mar 2022 Form 4 Insider Report for Imago BioSciences, Inc.

Role
Company's Chief Operating and Business Officer
Signature
/s/ Hugh Rienhoff, as Attorney-in-fact for Michael Arenberg
Issuer symbol
N/A
Transactions as of
23 Mar 2022
Net transactions value
$0
Form type
4
Filing time
25 Mar 2022, 16:13:50 UTC
Previous filing
10 Jan 2022
Next filing
14 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Stock Option (Right to Buy) Award $0 +371,000 $0.000000 371,000 23 Mar 2022 Common Stock 371,000 $18.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from March 23, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Remarks:

Company's Chief Operating and Business Officer